ArticleRSC chemical biology2025
Unravelling the role of key amino acid residues of the parainfluenza fusion peptide in membrane fusion.
Article in RSC chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parainfluenza viruses enter host cells by fusing their envelope with the cell membrane. In this process mediated by the fusion glycoprotein, the fusion peptide plays an essential role in membrane binding and triggering fusion. Previously, we demonstrated that the parainfluenza fusion peptide (PIFP) oligomerizes into porelike structures within the membrane, leading to membrane perturbations, fusion, and leakage. Additionally, we identified two key amino acid residues in the PIFP, F103 and Q120, which are important in inducing lipid tail protrusion and maintaining peptide-peptide interactions, respectively. Here, we seek to elucidate the role of these two residues in the PIFP function by studying the impact of F103A and Q120A substitutions on peptide activity. We compared the substituted peptides with the native peptide using biophysical experiments and molecular dynamics (MD) simulations. Our results show that the F103A substitution significantly impairs PIFP's interaction with the membrane and its ability to induce lipid mixing and membrane leakage in experimental assays. Moreover, a decrease in lipid perturbation and water flux through the membrane was observed in the MD simulations. In contrast, the Q120A substitution appears to have minimal impact on membrane interaction and PIFP-induced membrane leakage. Interestingly, a pronounced change in the interpeptide interactions within the membrane of the substituted peptides was observed in the MD simulations. These findings provide crucial insights into the potential role of F103 and Q120 in PIFP activity: the N-terminal phenylalanine (F103) is pivotal for membrane insertion and fusion, while the Q120 is crucial for regulating peptide oligomerization and pore formation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.